Peli BioThermal, the global name in temperature controlled packaging solutions, announces the relocation of its Minnesota-based corporate headquarters from Plymouth to Maple Grove, MN. The new space adds 40 percent more square footage, positioning the company to meet increasing demand for thermal packaging that maintains the efficacy of blood supplies, tissues, biologics, pharmaceuticals, diagnostics, and vaccines during transit.
“COVID-19 vaccines and therapeutics created unprecedented demand for temperature controlled packaging,” said David Williams, president of Peli BioThermal. “Fast-growing markets like cell and gene therapy will continue to increase demand and the need for product innovation. Our new building will allow us to achieve the capacity we need to grow and evolve alongside our customers.”
Located at 10050 89th Avenue North in Maple Grove’s Red Rock Business Park, the new facility is over 100,000 square feet. The space will include additional production lines and will house Peli BioThermal’s 80 plus Minnesota-based employees, with room for future growth.
Earlier this year Peli BioThermal shared its plans to evolve its offerings, including launching an additional portfolio of thermal shippers, rental programs, outsourcing services and new technology that connects all aspects of the cold chain for its customers. The company will also add new service centers to support the expanded offerings, growing its already robust and unmatched global network.
Visit http://www.pelibiothermal.com/ to learn more about the wide range of Peli BioThermal products and offerings.
Peli BioThermal is a division of Pelican Products, Inc., which is a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco.
